Grant to develop a new innovative product
The Danish Innovation Fund has granted Solural Pharma 1.5 mio DKK for together with Contera Pharma ApS (part of Bukwang Pharmaceuticals Co Ltd) , Dr. Sandra Klein, the University of Greifswald and Erweka Gmbh, to develop a new innovative product for the treatment of Morning Akinesia in Parkinson Patients.
- Updated Manufacturing and Importation Authorisation February 13, 2018
- Solural Pharma gets a European patent August 9, 2017
- Ascelia Pharma AB acquires Oncoral Pharma ApS June 30, 2017